美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=TREPROSTINIL"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
TREPROSTINIL 203649 001 ANDA TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS 1MG/ML No No 2017/11/30 2017/11/30 SANDOZ INC Prescription
TREPROSTINIL 203649 002 ANDA TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS 2.5MG/ML No No 2017/11/30 2017/11/30 SANDOZ INC Prescription
TREPROSTINIL 203649 003 ANDA TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS 5MG/ML No No 2017/11/30 2017/11/30 SANDOZ INC Prescription
TREPROSTINIL 203649 004 ANDA TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS 10MG/ML No No 2017/11/30 2017/11/30 SANDOZ INC Prescription
TREPROSTINIL 209382 001 ANDA TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS 1MG/ML No 2019/09/24 PAR STERILE PRODUCTS Prescription
TREPROSTINIL 209382 002 ANDA TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS 2.5MG/ML No 2019/09/24 PAR STERILE PRODUCTS Prescription
TREPROSTINIL 209382 003 ANDA TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS 5MG/ML No 2019/09/24 PAR STERILE PRODUCTS Prescription
TREPROSTINIL 209382 004 ANDA TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS 10MG/ML No 2019/09/24 PAR STERILE PRODUCTS Prescription
TREPROSTINIL 206648 001 ANDA TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS 1MG/ML No 2019/09/26 TEVA PHARMS USA Prescription
TREPROSTINIL 206648 002 ANDA TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS 2.5MG/ML No 2019/09/26 TEVA PHARMS USA Prescription
TREPROSTINIL 206648 003 ANDA TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS 5MG/ML No 2019/09/26 TEVA PHARMS USA Prescription
TREPROSTINIL 206648 004 ANDA TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS 10MG/ML No 2019/09/26 TEVA PHARMS USA Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2019 DrugFuture->U.S. FDA Drugs Database